[1] L.JACKSON ROBERTS II Brian J S. Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis[J]. Prostaglandins, 1985, 30 3: Pages 383-400. DOI:
10.1016/0090-6980(85)90114-5[2] HAYAISHI O. Sleep-wake regulation by prostaglandins D2 and E2.[J]. The Journal of Biological Chemistry, 1988, 263 29: 14593-14596.
[3] H ONOE. Prostaglandin D2, a cerebral sleep-inducing substance in monkeys.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1988, 85 11: 4082-4086. DOI:
10.1073/pnas.85.11.4082[4] Y KIKUCHI. Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.[J]. Cancer and Metastasis Reviews, 1994, 13 3-4: 309-315. DOI:
10.1007/bf00666101[5] BRENDAN J. WHITTLE . Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist[J]. Biochemical pharmacology, 2012, 84 1: Pages 68-75. DOI:
10.1016/j.bcp.2012.03.012[6] OYEBOLA O OYESOLA. The Prostaglandin D2 Receptor CRTH2 Promotes IL-33-Induced ILC2 Accumulation in the Lung.[J]. Journal of immunology, 2020, 204 4: 1001-1011. DOI:
10.4049/jimmunol.1900745[7] AKIKO SUGANAMI. Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands[J]. The FEBS journal, 2016, 283 21: 3931-3940. DOI:
10.1111/febs.13899[8] D F WOODWARD. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).[J]. Journal of Pharmacology and Experimental Therapeutics, 2003, 305 2: 772-785. DOI:
10.1124/jpet.102.047837[9] P. WAFFO-TéGUO. Potential Cancer-Chemopreventive Activities of Wine Stilbenoids and Flavans Extracted From Grape (Vitis vinifera) Cell Cultures[J]. Nutrition and Cancer-An International Journal, 2001, 40 1: 173-179. DOI:
10.1207/s15327914nc402_14